DavidE.GellerMD
Pediatric Pulmonology • San Diego, CACystic Fibrosis Pulmonology
VP of Pulmonary and Rare Diseases at Arcturus Therapeutics
Dr. Geller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
10628 Science Center Dr
Suite 250
San Diego, CA 92121- Is this information wrong?
Education & Training
University of Arizona College of Medicine-TucsonFellowship, Pulmonary Disease and Critical Care Medicine, 1983 - 1986
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 1980 - 1983
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1980
Certifications & Licensure
FL State Medical License 1988 - 2025- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trials.Bell, S. C.,Barry, P. J.,De Boeck, K.,Drevinek, P.,Elborn, J. S.,Plant, B. J.,Minić, P.,Van Braeckel, E.,Verhulst, S.,Muller, K.,Kanters, D.,Bellaire, S.,de Kock, H.,G...> ;J. Cyst. Fibros.. 2019 May 06
- 52 citationsA phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT...Patrick A. Flume, Donald R. VanDevanter, Elizabeth E. Morgan, Michael N. Dudley, Jeffery Loutit, Scott C. Bell, Eitan Kerem, Rainald Fischer, Alan R. Smyth, Shawn D. A...> ;Journal of Cystic Fibrosis. 2016 Jul 1
- 25 citationsInhalation of tobramycin using simulated cystic fibrosis patient profiles.Alfred Haynes, David E. Geller, Jeffry G. Weers, Brian Ament, Richard Pavkov, Richard Malcolmson, Laurie DeBonnett, Paul Mastoridis, Anthony Yadao, Silvia Heuerding> ;Pediatric Pulmonology. 2016 Apr 1
- Join now to see all
Industry Relationships
- Medical Director, AbbVie, IncMedical lead for cystic fibrosis CFTR modulator programDisclosure: Employee2014 - 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
